Superior Court Approves $2.5 Million Risperdal Verdict
Superior Court Approves $2.5 Million Risperdal Verdict
Introduction
On October 31, 2018, a unanimous three-judge panel in the Pennsylvania Superior Court upheld the $2.5 million Risperdal verdict awarded to an Alabama boy, who developed breasts due to the antipsychotic drug.
The case was the first among thousands of other product liability lawsuits filed against J&J. In August 2015, J&J appealed to overturn the verdict awarded to the plaintiff. The plaintiff was on Risperdal to treat his autism-related behavioral issues, and his parents claimed his abnormal breast growth was the result of the drug's side effect.
More than 7,000 Risperdal product liability lawsuits against J&J are filed in the Pennsylvania State Court. Two coordinated actions have been filed for Risperdal cases: one in Los Angeles Superior Court (Risperdal and Invega Product Liability Cases, JCCP 4775) and the other in Philadelphia (In Re: Risperdal Litigation, March 2010 Term, Case No. 100300296).
Comments
Latest News
Court Approves $700M Opioid Settlement for Acute Hospitals
Categories: Opioids
A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.
The settlement consolidates four separate agreements involving major drug…
Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B
Categories: Philips CPAP/BiPAP/ASV Sleep Apnea Machines
Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.
The breakdown of the foam in these machines may release harmful chemicals, raising serious…
Texas Trial to Decide J&J’s $10B Talcum Powder Settlement
Categories: Talcum
A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…